Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6496905

Cc1cc(C)c(-c2nc(N)ncc2-c2ccc(Cl)nc2)c(C)c1.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.46
ADORA1 P30542 9/20 0.44
ADORA2A P29274 6/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
MAPK10 P53779 1/20 0.41
PTK2B Q14289 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
DHFR P00374 1/20 0.39
POLB P06746 1/20 0.39
PIK3CD O00329 1/20 0.39
LCK P06239 1/20 0.39
KDR P35968 1/20 0.39
JAK3 P52333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL6500606 0.82 KMT2A (0.48) RPS6KA3ADORA1ADORA2AKMT2AMEN1
SCHEMBL4400611 0.78 TNIK (0.38) RPS6KA3ADORA1ADORA2AKMT2AMEN1
Ammonia Solution, Strong SCHEMBL6529235 0.77 MAPKAPK2 (0.54) RPS6KA3ADORA1ADORA2AKMT2AMEN1
Ammonia Solution, Strong SCHEMBL4399088 0.77 ADORA1 (0.48) RPS6KA3ADORA1ADORA2ATP53MAPT
Ammonia Solution, Strong SCHEMBL6527759 0.76 MAPT (0.46) RPS6KA3ADORA1ADORA2AKMT2AMEN1
Ammonia Solution, Strong SCHEMBL4401603 0.76 DYRK1A (0.47) RPS6KA3ADORA1ADORA2AKMT2ADHFR
SCHEMBL17426503 0.75 PIK3CD (0.46) KMT2AMEN1PIK3CD
SCHEMBL1554173 0.75 ADORA1 (0.70) RPS6KA3ADORA1ADORA2AKMT2A
Ammonia Solution, Strong SCHEMBL6500596 0.75 QPCT (0.46) RPS6KA3ADORA1ADORA2AKMT2ATP53
Ammonia Solution, Strong SCHEMBL4396798 0.74 ADORA1 (0.42) RPS6KA3ADORA1ADORA2AKMT2ADHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004125-A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) JANSSEN PHARMACEUTICA N.V. (BE) 2005-01-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004125-A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) GSK3B, GSK3A, GSKIP RPS6KA3 33/4885ADORA1 1486/4885ADORA2A 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.